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Abstract. Protein kinase C Ix (PKCIx) displays unusual 
structural features like a pleckstrin homology domain 
and an amino-terminal hydrophobic region with a puta- 
tive leader peptide and transmembrane sequence. As a 
discrete location often is a direct clue to the potential 
biological function of a kinase, antibodies directed 
against unique amino- and carboxy-terminal domains 
of PKCI~ were used to localize the protein within intra- 
cellular compartments in immunofluorescence and sub- 
cellular fractionation studies. Confocal laser scanning 
microscopy showed colocalization of PKCIx with the 
resident Golgi marker protein 131,4 galactosyltrans- 
ferase in PKC~ transfectants and in the human hepato- 
cellular carcinoma cell line HepG2, expressing endoge- 
nous PKCIx. Long-term treatment of cells with 
brefeldin A, which disintegrates the Golgi apparatus, 
disrupted PKCtx-specific staining. Cosegregation of 
PKCI~ with 131,4 galactosyltransferase, but not with the 
endosomal marker rab5, upon density gradient frac- 
tionation and Western blot analysis of HepG2 cell ex- 
tracts, provides independent evidence for a Golgi local- 
ization of PKCIx. Moreover, cellular sulfate uptake and 
Golgi-specific glycosaminoglycan sulfation was en- 
hanced in PKCIx transfectants. Together, these data 
suggest that PKCIx is a resident protein kinase of the 
core Golgi compartment and is involved in basal trans- 
port processes. 
T 
HE  protein  kinases  C  (PKC) 1 define  a  family of 
serine/threonine-specific  kinases  that  are  consid- 
ered as important regulatory enzymes involved in 
multiple  cellular responses.  They  are  activated  by  lipid 
second messengers, predominantly diacylglycerol (Nishi- 
zuka, 1992),  in response to various extracellular agonists 
like hormones, neurotransmitters, growth factors, and cy- 
tokines (Hug and Sarre, 1993; Dekker and Parker, 1994). 
So far, 11  PKC isoforms have been characterized at the 
molecular level.  Based  on  the  primary structure  and  in 
vitro  activation  requirements,  the  PKC  family  can  be 
grouped into three major classes:  Ca2+-dependent PKCs 
(cPKCe~, [31, [32, and ~/) (Knopf et al.,  1986),  Ca2+-inde  - 
pendent, novel PKCs (nPKCe, ~, 11, and 0)  (Ohno et at., 
1988; Ono et al., 1988; Osada et al., 1990, 1992), and atypi- 
cal PKCs (aPKC~ and w/X; Ono et al., 1989; Selbie et al., 
1993; Akimoto et al.,  1994). The recently identified novel 
member PKCIx and its mouse homologue protein kinase D 
(PKD) do not conform to either one of these major classes 
and thus may comprise a new subgroup (Johannes et al., 
1994; Valverde et al., 1994; Dekker and Parker, 1994). The 
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lack of a typical pseudosubstrate site as well as the pres- 
ence of two unique amino-terminal hydrophobic domains, 
together with the unusually large size of the molecule, are 
characteristic features of PKCIx/PKD. Furthermore,  the 
presence of a pleckstrin homology (PH) domain (Gibson 
et al.,  1994) in the regulatory region of PKCIx/PKD is so 
far unique within the  PKC family. The  novel structural 
features of the isozyme are corroborated by analysis of in 
vitro kinase activity of PKCIx, revealing a distinct sensitiv- 
ity profile to various kinase inhibitors with strong inhibi- 
tion of constitutive kinase activity by the typical protein 
kinase A inhibitor H89 (Johannes et al., 1995; Dieterich et 
al., 1996). Moreover, expression and functional analysis of 
PKD showed an atypical substrate specificity in vitro (Val- 
verde et al.,  1994; Van Lint et al.,  1995).  At present, the 
understanding of the physiological role of the various PKC 
members including PKCIX is still limited. Nevertheless, the 
available  structural  and  biochemical  data  suggest  that 
PKCtx is likely to have a cellular function that differs from 
other PKC subtypes. 
As complex processes of cellular metabolism require a 
high degree of functional organization, which is achieved 
by compartmentalization into organelles, a  first step  to- 
ward understanding the biological function of novel pro- 
teins is made by an analysis of tissue-specific expression 
and subcellular location. For several PKC isozymes, an ex- 
perimental model of dynamic compartmentalization indi- 
cates  that, upon  binding of physiological activators, en- 
zyme  activation  leads  to  the  translocation  of  cytosolic 
© The Rockefeller University Press, 0021-9525/96/09/1401 / 10 $2.00 
The Journal of Cell Biology, Volume ] 34. Number 6, September 1996 1401-1410  1401 PKCs  to  the  particulate  fraction such  as  plasma  mem- 
brane, nucleus, or cytoskeletal structures (Hug and Sarre, 
1993).  Other PKC isozymes are not translocated upon ac- 
tivation,  but  they appear  to be constitutively associated 
with distinct organelles (Goodnight et al.,  1995; Germano 
et  al.,  1994;  Chida  et  al.,  1994),  although,  for the  same 
isozyme, different locations have been described for dif- 
ferent cell types (Germano et al., 1994; Goodnight et al., 
1995). Despite potentially selective intracellular locations, 
as yet there is no definitive proof of a given isotype being 
activated in a specific location that would lead to the phos- 
phorylation of a selective substrate. Nevertheless, tissue- 
specific expression and  differential intracellular location 
suggest  distinct functions  of individual  PKC  isotypes in 
signal transduetion and cellular metabolism. 
To obtain insights  into the potential biological role of 
PKCIz, we have used PKCl~-specific antibodies and anti- 
sera to localize PKCI~ within subcellular compartments of 
stable transfectants and cell lines expressing endogenous 
PKCI~.  Using indirect immunofluorescence and confocal 
laser scanning microscopy, as well as subcellular biochemi- 
cal fractionation, we demonstrate that PKCIx is located at 
the Golgi complex. Furthermore, sulfate uptake as well as 
Golgi-specific sulfation and release of glycosaminoglycan 
(GAG) chains were found to be enhanced in PKCIx trans- 
fectants, indicating an involvement of PKCtx in constitu- 
tive transport processes at the Golgi apparatus. 
Materials and Methods 
Cell Culture and Transfection 
HeLa, CHO, and NIH3T3 (all obtained from American Type Culture Col- 
lection, Rockville,  MD) were transfected with PKCI~ within the pBMGneo 
vector as previously described (Johannes et al., 1994). In the case of CHO 
and NIH3T3 cells, neomycin selection was carried out in the presence of 
1 mg/ml G418-sulfate  (GIBCO BRL, Gaithersburg, MD) for 15 d before 
picking individual  clones.  PKCp,  expression of transfectants was verified 
by immunoprecipitation at the time of the experiments. 
Immunoprecipitation and Autophosphorylation 
The production of an mAb JP1 directed against an amino-terminal PKC~/ 
glutathione-S-transferase fusion protein  has  been  described  previously 
(Johannes et al.,  1994). It was used for immunoprecipitation and immu- 
nofluorescence studies (see below). In addition, a polyclonal rabbit antise- 
rum, raised against a synthetic peptide corresponding to the carboxy-ter- 
minal lg amino acids of PKC~z (generously provided by D. Fabbro, Ciba 
Geigy, Switzerland),  was used for immunodetection. For immunoprecipi- 
tation of PKC~ from the cell line HepG2, cells were lysed by sonification 
and  subsequent incubation  in lysis buffer (20  mM Tris, pH 7.4, 2  mM 
EDTA, 1 mM EGTA, 1% Triton X-100, 150 mM NaCI, 10 Ixg/ml leupep- 
tin, 3 p.g/ml trasylol,  1 mM PMSF) for 30 min at 0°C. After centrifugation 
of cell debris, immunoprecipitation was performed with anti-PKCp,  mAb 
(3 i~g per 107 cells) for 4 h at 4°C. Immunocomplexes  were isolated by in- 
cubation with protein  G-Sepharose for 30  min at 4°C,  washed in lysis 
buffer, and resuspended in 40 p.I phosphorylation buffer (20 mM Tris, pH 
7.4, 5 mM magnesium acetate,  1 mM DTT). The reaction was started by 
adding 0.3 txl [~-32p]ATP (5,000 Ci/mmol, 10 mCi/ml; Amersham Buchler 
GmbH, Braunschweig, Germany) and incubated for 10 min at 37°C. Reac- 
tions were terminated by adding an equal volume of sample buffer, re- 
solved by SDS-PAGE under reducing conditions, dried, or transferred to 
nitrocellulose membrane, and 32p-labeled proteins were visualized  by au- 
toradiography. Western blot analyses of COS PKCIx and of HeLa PKCtx- 
expressing transfectants (Johannes et al., 1995), as well as of the parental 
cell  lines  (equivalents of 0.5  ×  106  cells  analyzed  in  each  lane)  and of 
HepG2 immunoprecipitates, were performed with anti-PKCIx  mAb (0.5 
txg/ml) or rabbit immune serum at  a  1:250 dilution  using an enhanced 
chemiluminescence  detection  system  (Boehringer  Mannheim  GmbH, 
Mannheim, Germany) according to the manufacturer's instructions. 
Immunofluorescence Staining  and Confocal Laser 
Scanning Microscopy 
Cells were grown on coverslips to 70% confluency, washed with PBS, and 
fixed in 3.5%  paraformaldehyde in PBS for 15 min at room temperature. 
Permeabilization of the cells proceeded through incubation with 0.5%  sa- 
ponin, 0.2% BSA, 2% FCS, and 5 mM MgCl2 in PBS for 4 min. All further 
washes and incubations were carried out in the same solution containing 
0.05% saponin. For detection of [31,4 galactosyltransferase and/or PKCIx, 
cells were incubated for 2 h with an anti-lM,4 galactosyltransferase antise- 
rum (obtained from E. Berger, University of Ztirich,  Switzerland) diluted 
1:50 and/or with an anti-PKCiz  mAb (0.3 Ixg/l~l), followed by incubation 
with goat anti-rabbit IgG-FITC conjugate and/or goat anti-mouse IgG- 
Cy3 conjugate (Sigma Chemical GmbH, Munich, Germany) for 1 h. The 
coverslips were mounted in Moviol mountant supplemented with 0.1% 
p-phenylendiamine  and  photographed with  a  fluorescence  microscope 
(Axiovert; Zeiss, Oberkochen, Germany). Confocal laser scanning images 
were taken by a Fluovert microscope using a TCS4D scanner (Leica In- 
struments GmbH, Nussloch. Germany). Excitation intensities of both flu- 
orescent dyes were cross-corrected, and areas of colocalization  were rep- 
resented in blue. The optical  slice in z-direction corresponds to 05  txm. 
Brefeldin A incubations were performed at a final concentration of 2 ~g/ 
ml for 30 min at 37°C. PMA stimulation of HepG2 cells was performed at 
100 ng/ml for 20 min. 
SubceUular Fractionation 
Isolation of Golgi membrane-enriched subcellular fractions by velocity- 
controlled  sucrose  gradient  fractionation  was  performed  as  described 
(Balch et al.~ 1984). In brief, 4 × 107 HepG2 cells were resuspended in 1.75 
ml 0.25 M sucrose, 10 mM Tris/HC1, pH 7.4, and homogenized by applying 
20 strokes with a "very tight-fitting" 5-ml Dounce homogenizator (Braun, 
Melsungen, Germany). The cellular  extract was adjusted to 1.4 M sucrose 
by adding 1.75 ml 2.3 M sucrose and overlaid upon two layers of 0.6 ml 
2 M sucrose and 1.2 ml 1.6 M sucrose. The cellular  extract was overlaid 
with 3.5 ml 1.2 M sucrose and 2.3 ml 0.8 M sucrose and centrifuged in a ro- 
tor (SW28, Beckman Instruments, Inc., Palo Alto, CA) for 2.5 h at 25,000 
rpm. Three distinct  interphases, as shown schematically  in Fig. 4, were ob- 
tained. Equal amounts of protein (10 Ixg for 131,4 galactosyltransferase and 
30 Ixg for PKC/~ and rab5 detection) in each lane were applied to a  10 or 
12%  SDS-PAGE, followed by Western blot analysis using either an anti- 
PKCIx (Johannes et al., 1995) or an anti-[31,4 galactosyltransferase (Nils- 
son et al.,  1993) antiserum in a  1:1,000 dilution using an alkaline  phos- 
phatase-based detection system. The rab5-specific  antiserum (Santa Cruz 
Biotechnology, Santa Cruz, CA), serving as a marker for the early endo- 
some, was used in a dilution 1:250. 
Quantitative evaluation of Western blots was performed by densito- 
metric  scanning using a  video  imaging system with Bioprofil  Software 
(Froebel, Lindau, Germany). Arbitrary units of PKCIx and 131,4 galacto- 
syltransferase  were  estimated  by  scanning  the  alkaline  phosphatase- 
stained blots. The Western blot signal obtained from 10 Ixg lysate for 131,4 
galactosyltransferase, and 30 p.g lysate  in the case of PKCg,,  was set at 
one, and relative amounts of fractionated antigen were calculated  by mul- 
tiplying arbitrary units with the total protein content of each fraction. 
Sulfation of Glycosaminoglycans 
As an indicator of Golgi-specific  function, GAG was measured by a modi- 
fication  of the GAG release assay described by Miller  and Moore (Miller 
and Moore, 1991; Lehel et al., 1995) for a 6- or 24-well plate.  Transfectants 
were grown to confluence (5 x  105 cells for the 6-well plate and 3 × 10  "~ for 
the 24-well plate) and serum starved overnight. Expression of PKCI~ was 
induced by adding I IxM CdCI2 for 4 h. Serum-deprived ceils were induced 
30 min with the xylose analogue 4-metbylumbelliferyl 13-o-xyloside (desig- 
nated  xyloside)  at  a  final  concentration  of 1 mM in  buffer A  (20  mM 
Hepes, pH 7.2, 110 mM NaCl, 5.4 mM KCI, 0.9 mM Na2HPO4,  10 mM 
MgC12,  2  mM  CaCle,  1  g/liter  glucose).  The  cells  were  labeled  with 
Na2135S]SO4 (Amersham Buchler GmbH; 17  IxCi per well  in  300  Ixl of 
buffer A for the kinetics,  and 5.5 IxCi per well in 150 txl for all other exper- 
iments) for 10 min, rapidly washed with l ml DMEM containing 4 mM un- 
labeled  Na2SO4, and  subsequently incubated  in  1 ml  DMEM  to  allow 
GAG secretion. To measure the kinetics  of GAG chain secretion. 50-~1 
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and 150 t~1 of buffer A, chondroitinsulfate (5 I~1 of a 10 mg/ml stock solu- 
tion), and cetylpyridinium chloride (5 ~1 from a 10% wt/vol solution) was 
added. GAG chains were precipitated at 37°C for 1 h. Precipitates were 
collected on a  nitrocellulose-covered microtiter  plate  (Pall  Biosupport, 
East Hills, NY) and washed with 0.8 ml 1% cetylpyridinium chloride and 
40 mM Na2SO4 per well. The filters were dried and counted in 2 ml scintil- 
lation fluid. At the end of the experiment, the cells were lysed in 0.5 ml of 
buffer B (10 mM Hepes, pH 7.5, 1.5 mM MgC12, 10 mM KC1, 0.1% Triton 
X-100),  and  200  Ixl  aliquots were  subjected  to  the  BCA  assay (Pierce 
Chemical Co., Rockford, IL) to estimate the protein content. 
Sulfate Uptake 
To measure sulfate uptake into intact cells in the presence of xyloside, 105 
cells growing on 24-weU plates were processed as described for the GAG 
chain precipitation.  Cells were  labeled with 5.5  ~LCi Na2135S]SO4 for 10 
rain. After three washes with 0.4 ml DMEM, cells were harvested in 400 
Ixl buffer B. 35S-incorporation was determined by measuring 100-~I ali- 
quots in 2 ml scintillation fluid. The protein content of each culture was 
determined using the BCA assay (Pierce Chemical Co.). Nonspecific sul- 
fate uptake was measured by a brief incubation of PKCIx and vector con- 
trol transfectants with [35S]sulfate  on ice followed by three washes with 
500  V.1  DMEM.  Nonspecific  binding  to  the  cells  was  <10%  of  total 
[35S]sulfate  uptake.  No  significant differences between  PKCIx transfec- 
tants and vector controls were detected. All assays concerning GAG se- 
cretion and sulfate uptake were performed in triplicate. Results shown are 
representative of at least three similar experiments. 
Results 
Localization of  PKCl~ by Indirect Immunofluorescence 
To analyze the intracellular location of PKCIx, previously 
described stable PKCwexpressing transfectants of COS-1 
and HeLa cells (Johannes et al., 1994) were used for im- 
munocytochemical analysis.  Immunostaining of  the  re- 
spective transfectants was performed using the previously 
described mAb JP1  (Johannes et al., 1995).  In both COS 
and HeLa transfectants, the immunofluorescence signals 
were focused in caplike perinuclear structures, becoming 
weaker towards the peripheral cytoplasm (Fig.  1,  C  and 
G). Specific staining of the nucleus or the plasma mem- 
brane was not observed in either transfectant (Fig.  1, C 
and G). No immunoreactive signals could be detected in 
the nontransfected parental cell lines (Fig. 1, A and E, vs C 
and G, respectively; see also Fig. 2, lanes 2 and 4 vs lanes 1 
and 3). The stained subcellular structures in COS transfec- 
tants  produced  a  higher  fluorescence  intensity as  com- 
pared  with  HeLa  transfectants,  which  is  in  accordance 
with the higher expression of PKC~ in the former, as re- 
vealed by Western blot analysis (see Fig. 2, lane 1 vs lane 3). 
HepG2 Cells Do Express Endogenous PKCtz 
Northern blot data from human tissues as well as reverse 
transcription-PCR from several cell lines (Johannes et al., 
1994; data not shown) provided evidence that endogenous 
PKCIx transcripts  are  expressed  at  relatively low  abun- 
dance.  As  the  above  data  suggested  that  PKCtx  might 
function as Golgi-specific PKC, cell lines established from 
secretory tissues were assayed for PKCIx expression. The 
human hepatocellular carcinoma celline HepG2 (Aden et 
al., 1979) was identified as constitutively expressing signifi- 
cant amounts of PKCIx. Immunoprecipitation and subse- 
quent Western blot detection with the mAb JP1, as well 
as  with  the  polyclonal  rabbit  antiserum,  revealed  that 
HepG2-derived PKCIz migrates as a single band at ~115 
kD, in a similar fashion to the recombinant gene product 
of COS and HeLa cell transfectants (Fig. 2, lane 5 vs lanes 
1 and 3). As expected, HepG2-derived PKCIx showed the 
same  cofactor-independent autophosphorylation activity 
as recombinant PKCtx expressed in transfectants (Fig. 2, 
lane 6; Johannes et al.,  1995). PKCtx could be readily de- 
tected in ~0.5  x  106 cell equivalents in transfectants by 
Western blot analysis and in 2 x  106 equivalents of HepG2 
cells by immunoprecipitation. 
Localization of  PKCI~  at the Golgi  Apparatus by 
Confocal Laser Scanning Microscopy 
From previously reported biochemical fractionation stud- 
ies, PKCIx has been  localized in the  particulate cellular 
fraction (Johannes et al., 1995).  In an attempt to identify 
more precisely the location of PKCt~ in subcellular struc- 
tures,  immunofluorescence double-labeling  experiments 
using antibodies  against  a  variety of cytoskeletal or or- 
ganeIle-specific proteins were performed.  No  colocaliza- 
tion of PKC~ with actin-containing stress fibers, vimentin- 
containing intermediate filaments, or Traps as a marker of 
the  ER  (Hartmann et  al.,  1993)  was  detected (data not 
shown). 
A conformity in the staining patterns was found in cells 
labeled in parallel with FITC-coupled WGA that prefer- 
entially binds  to  Golgi  structures  (Henson  et  al.,  1992; 
Johnston  et  al.,  1994) and  the  PKCix-specific mAb  JP1 
(data not shown). A  similar localization pattern was ob- 
tained upon staining with an mAb against the coatomer 
protein  13-COP (Duden  et  al.,  1991; data  not  shown). 
13-COP is  a  main structural component of non-clathrin- 
coated vesicles, mediating transport between the RER and 
the cis-Golgi (Duden et al., 1991; Pelham, 1994). An over- 
lapping staining pattern of PKCIx with WGA and 13-COP 
suggested a  predominant association of PKC~x with the 
Golgi compartment. To scrutinize this prediction, costain- 
ing experiments were performed with a  well-established 
Golgi-specific marker enzyme, 131,4 galactosyltransferase, 
that has been localized to the medial cisternae of the Golgi 
(Nilsson et al., 1993). In Fig. 3, a representative colocaliza- 
tion experiment using confocal laser scanning microscopy 
of PKCIx (A, red fluorescence) and 131,4 galactosyltrans- 
ferase (B, green fluorescence) is shown for HeLa PKC~ 
transfectants  (upper panels) and  HepG2  cells  endoge- 
nously expressing PKCI~ (middle  and lower  panels). A com- 
puter-based superimposition by image processing yielded, 
in each case, an overlay of the 131,4 galactosyltransferase- 
specific signals with most of the PKC~-specific signal (Fig. 
3,  C, F, /, and L), indicating staining of the same  struc- 
tures. In addition, in both cell lines, a weaker PKC~-specific 
signal  was  found throughout cytoplasmic structures  not 
stained by the 131,4 galactosyltransferase-specific antibody 
(Fig. 2, A and D). Additional hints for a Golgi-localization 
of  PKCtx  were  obtained  by  brefeldin  A  treatment  of 
HepG2 cells. Long-term treatment of cells with brefeldin 
A, a fungal metabolite, results in complete disintegration 
of the highly organized Golgi structure (Bauernfeind and 
Huttner,  1993).  As  shown  in  Fig.  3,  G-l,  treatment  of 
HepG2 cells with brefeldin A for 30 min leads to a nearly 
complete disruption of both the PKCF- and the 131,4 galac- 
tosyltransferase-specific staining. Both signals disappeared 
Prestle et al. PKCtz Is Located at the Golgi Complex  1403 Figure 1.  Localization of PKC~ in transfectants by indirect immunofluorescence.  COS PKCIx- (C and D) and HeLa PKCIx- (G and H) 
expressing transfectants grown on coverslips were processed for immunofluorescence  as described in Materials and Methods. Cells were 
stained with the PKCl~-specific mAb JP1 and compared with the parental COS (A and B) or HeLa (E and F) cell line, respectively. 
PKC/~ was visualized with a Cy3-coupled goat anti-mouse IgG as secondary antibody in A, C, E, and G. (B, D, F, and H) Respective cells 
by light microscopy. Bar, 5 Ixm. 
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carcinoma cell line HepG2 and recombinant  PKCIx in transfec- 
tants. PKCIx is detected in extracts from COS and HeLa transfec- 
tants and not in the parental cell lines (lanes I  and 3 vs 2 and 4, 
respectively) by Western blot analysis. PKCIx  can be immunopre- 
cipitated  from HepG2 cells  (lane  5)  and  autophosphorylated 
(lane 6). Rabbit peptide antiserum was used for immuoprecipita- 
tion, and the mAb JP1 was used for Western blot detection. 
with  the same  kinetics in  brefeldin-treated HepG2 cells 
(data not shown), indicating that PKCIx and 131,4 galacto- 
syltransferase are localized to the same Golgi subcompart- 
ment. 
With the exception of the atypical isoforms, activation 
of PKCs by phorbol esters leads to a rapid redistribution 
of the enzyme, predominantly from cytosolic to membrane 
locations. We previously demonstrated that, despite a high 
affinity phorbol  ester  binding  of recombinant  PKCIx in 
vitro (Dieterich et al., 1996), the phorbol ester binding ca- 
pacity  of  extracts  from  PKCIx  transfectants  was  only 
slightly  increased,  and  long-term  treatment  of  PKCIx 
transfectants with phorbol esters  did not  lead  to  a  pro- 
teolytic degradation (Johannes et al.,  1994), as is typical 
for other PKC subtypes (Hug and Sarre, 1993).  Next, we 
investigated whether PMA treatment affects the localiza- 
tion of PKCIx. Upon a 20-min PMA treatment of HepG2 
cells, no translocation of PKCIx could be detected (Fig. 3, 
J-L).  Interestingly,  PMA  treatment  of HepG2  cells  af- 
fected the morphology of the  Golgi  apparatus  with  an 
apparent condensation of both PKCp~ and t31,4 galactosyl- 
transferase (Fig. 3, J-L). This is probably due to consid- 
erable changes in the cytoskeletal structures, involving a 
reorganization  of  actin  filaments  upon  PMA  treatment 
(Prestle, J., unpublished observations). 
Copurification of PKCl~ with ill,4 
Galactosyltransferase in Fractionated Cell Extracts 
The predicted Golgi association of PKCIx was investigated 
in an independent biochemical approach by Western blot 
analyses of isolated Golgi membranes. From HepG2 cells 
expressing endogenous PKCIx (Fig. 2), Golgi membrane- 
enriched subcellular fractions were isolated by differential 
cell fractionation on sucrose cushions (Balch et al., 1984). 
As judged upon SDS-PAGE and Western blot analysis of 
fractions from sucrose layers, most of the 131,4 galactosyl- 
transferase and PKC~ immune reactivity was found in the 
interphase  between  the  1.4  and  1.6  M  sucrose  cushions 
(Fig.  4,  fraction 6).  Both  PKC~  and  Golgi  membrane- 
bound  131,4 galactosyltransferase  were  recovered in  the 
same fractions using a rabbit serum directed against a car- 
boxy-terminal epitope of PKC~ and an antiserum against 
131,4 galactosyltransferase, showing copurification of both 
proteins (Fig. 4). Calculation of the relative distribution of 
PKCIx  showed  similar  distribution  with  ~41%  of total 
131,4 galactosyltransferase recovered in interphase I (frac- 
tion 6), in which peak activity (55%) of PKC~ was also de- 
tected (see Table I). 
The Golgi membrane-enriched fractions from endoge- 
nous PKCix-expressing HepG2 cells were further analyzed 
for the  presence  of  a  marker  protein  representative  of 
other subcellular compartments. The distribution of rub5, 
a member of the rub GTPase family (Pfeffer, 1994), which 
acts as a regulatory factor in the early endocytic pathway 
and is considered a marker of the early endosome (Bucci 
et al., 1992), was used as an indicator to verify appropriate 
separation of the distinct organelle membranes during the 
fractionation procedure. As shown by Western blot analy- 
sis of the sucrose gradient fractions (Fig. 4, lower panel), 
the peak activity of rub5 was found ,in fraction 2  (repre- 
senting interphase III), which is clearly separated from the 
peak of 131,4 galactosyltransferase and PKQz (Fig. 4, frac- 
tion 6). 
HeLa PKClx Transfectants Show an 
Enhanced Sulfate Uptake and Constitutive Secretion 
of Sulfated Glycosarainoglycans 
Previous studies have established that the Golgi apparatus 
is the exclusive site for sulfation reactions (Vertel et al., 
1993). The measurement of incorporated 35S-labeled  sul- 
fate into glycosaminoglycans can be used to follow consti- 
tutive protein secretion in cells (Miller and Moore, 1991; 
Chanat and Huttner, 1991). To determine whether Golgi- 
associated PKCIx might modulate Golgi function, the ki- 
netics  of  GAG  release  was  measured  in  HeLa  PKCIx 
transfectants and compared with mock-transfected HeLa 
cells. As shown in Fig. 5 A, PKC~ transfectants displayed 
an enhanced sulfation rate, as evident from 89% of GAG 
secretion of HeLa transfectants  compared with  60%  of 
vector controls. The enhanced glycosaminoglycan release 
could be confirmed in several independent HeLa PKCIx 
cell clones (Fig. 5  B). In  addition to the analyzed HeLa 
transfectants, PKC~-expressing cell lines originating from 
different tissues and species were established. In CHO and 
NIH3T3  transfectants,  PKC~  protein  expression  corre- 
lated with enhanced GAG chain secretion. As shown in 
Fig. 5 B, all PKCp, transfectants displayed an enhanced se- 
cretion capacity compared with the parental cell lines and/ 
or mock-transfected control clones. 
Sulfation of proteins is a multistep process in which the 
rate-limiting  reactions  can  occur  at  different  steps.  An 
early rate-limiting step is the transport of sulfate into cells 
and  further  on  to  the  Golgi  compartment.  Therefore, 
HeLa PKCIx transfectants were analyzed for differences in 
sulfate uptake. As shown in Fig. 6, both in the absence or 
presence of xyloside, HeLa PKC~ transfectants display an 
enhanced sulfate uptake compared with control transfec- 
tants or parental cells. Together, these data indicate an in- 
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PKCI~ in Purified Golgi Membranes by Sucrose Gradient 
Centrifugation 
Fraction  PKCIx  131,4 Gatactosyltransferase 
U  %  U  % 
1  0.2  0.3  0.4  0.1 
2  0.7  0.8  0.9  0.3 
3  0.5  0.5  2.9  0.9 
4  1.9  1.7  42.9  12.9 
5  15.1  13.7  43.1  12.9 
6  61.5  55  137  41.1 
7  31.1  28  105.8  31.7 
Cell Extract  111  100  333  100 
Arbitary units of PKCIx and 131,4 galactosyltransferase were estimated by scanning 
Western blots shown in Fig. 4. One arbitrary unit is defined as the signal detected with 
the PKCp, antiserum and with the [31,4 galactosyltransferase antiserum in 30 and I0 
Ixg total cellular extract, respectively. 
Figure4.  Copurification of PKC~ with 131,4 galactosyltransferase 
in  Golgi  membrane-enriched  subcellular  fractions.  40  ×  106 
HepG2  cells  were  homogenized  and  fractionated  on  sucrose 
cushions as indicated  at the top of the figure. TCA-precipitated 
fractions  were  subjected  to  SDS-PAGE,  followed  by  Western 
blot  analyses  with  a  PKCtx-,  131,4 galactosyltransferase-,  and 
rab5-specific polyclonal rabbit  antiserum as described in the Ma- 
terials and Methods section. Equal loading of each lane was veri- 
fied by Ponceau staining of the nitrocellulose membrane  before 
Western blot analysis. E, cellular extract. 
volvement of PKC~ in generation and/or secretion of sul- 
fated  glycosaminoglycans, potentially  by  regulating,  via 
phosphorylation, the activity of Golgi membrane-located 
transporters. 
Discussion 
Protein phosphorylation is a fundamental process in regu- 
lating cellular transport processes (Davidson et al.,  1992), 
and different lines of evidence have previously pointed out 
a role of PKCs in vesicular transport (Coffey et al.,  1993). 
A  requirement for PKC has been demonstrated in regu- 
lated exocytosis (Akita et al., 1994) and for the movement 
of cell surface  receptors through  the  endocytic pathway 
(Cardone et al., 1994). Moreover, a calphostin C-sensitive 
protein kinase  C, insensitive to downregulation by long- 
term phorbol ester treatment, has been postulated to be 
involved in the export of vesicular stomatitis virus glyco- 
protein from the ER to the cis-Golgi network (Fabbri et 
al., 1994). In other models, an undefined PKC subtype has 
been shown to play a critical role in the regulation of the 
assembly of GTP-dependent binding of the coat protein 
ADP-ribosylation factor and 13-COP to Golgi membranes 
in rat basophil leukemia cells (De Matteis et al.,  1994).  In 
the present study, we provide evidence for a constitutive 
location and functional role of PKCfx at  the core Golgi 
compartment of HepG2 cells and various transfectants by 
three distinct experimental approaches. First, indirect im- 
munofluorescence staining of PKCt~ revealed an exclusive 
caplike  staining pattern in  a  perinuclear region. Further 
analyses by confocal laser scanning microscopy, using the 
Golgi  marker  [31,4 galactosyltransferase  (Nilsson  et  al., 
1993) and a PKCix-specific antibody, showed that both sig- 
nals  could  be  superimposed.  Second,  independent  evi- 
dence for a Golgi association was obtained from cell frac- 
tionation studies on sucrose cushions (Balch et al.,  1984) 
and  subsequent  marker  colocalization  by  Western  blot 
analysis. Using this protocol for enrichment of Golgi mem- 
branes, PKC~ precisely comigrated in fractions containing 
the  Golgi-specific  marker  protein  131,4 galactosyltrans- 
ferase and segregated from the early endosomal marker 
rab5.  Third,  Golgi localization  and  selective function of 
PKCIx is corroborated by specific enhancement of cellular 
sulfate  uptake  and  of  sulfated  GAG  chain  release  in 
PKCp. transfectants of different origin, further indicating 
that PKC~x is a  resident Golgi protein in these cell lines. 
Therefore, we propose that PKC~ could be involved in the 
regulation of Golgi transport processes. 
Another PKC subtype, PKC~, has also been reported to 
be localized at the Golgi compartment (Lehel et al., 1995). 
Interestingly, both isozymes appear to be involved in regu- 
lation of secretion; PKCtx and PKC~ modulate Golgi-spe- 
cific glycosaminoglycan sulfation in cell culture, yet in op- 
posite  directions:  PKCIx  enhances  (Fig.  5)  and  PKCe 
Figure 3.  Colocalization of PKCIx with Golgi-specific marker proteins using confocal laser scanning microscopy. Hela PKC~x  transfec- 
tants (A-C) and HepG2 cells (D-L) were grown on coverslips and processed as described in Materials and Methods. (A, D, G, and J) 
PKC~-specific staining using the mAb JP1. (B, E, H, and K) 131,4 Galactosyltransferase-specific  staining using a polyclonal antiserum. 
(C) Superimposition of A and B after cross-correction of both fluorescence signals. Areas of colocalization (blue). (F) Combination of D 
and E, showing a colocalization of 131,4 galactosyltransferase  (GAIT) and PKCIx in HepG2 cells. (G-/) Same staining and overlay as in 
D-F for HepG2 cells after incubation for 30 min with brefeldin A (2 ixg/ml). (J and K) HepG2 cells after stimulation for 20 min with 
PMA (100 ng/ml). 
Prestle et al. PKCIz Is Located at the Golgi Complex  1407 Figure 5.  Enhanced secretion of sulfated glycosaminoglycans in PKCIx transfectants. (A) Kinetics of GAG release in a HeLa PKC~ 
transfectant compared with a vector control. Cells grown on 6-well plates were incubated overnight in serum-free DMEM. PKCIx ex- 
pression was induced by incubation with 1 ixg/ml CdC12 for 4 h. Cells were starved for 30 min in sulfate-free buffer A containing 0.5 mM 
xyloside, and then labeled for 10 min at 37°C with [35S]SO  4. The cells were washed to remove excess of [35S]504  and chased for 60 min in 
DMEM. At the indicated times,  aliquots were removed, and secreted GAG chains were precipitated as described in the Materials and 
Methods section. (B) Enhanced release of GAG chains in different cell types. The aSS-labeled GAG chains present in the medium and 
cell lysates were quantitated and added together. 3 x  105 cells were grown in 24-well plates and processed as described above. After a 
30-rain chase, GAG chains were precipitated from the cells and the supernatant in a filter assay, quantitated by liquid scintillation  count- 
ing, and added together. Cells were processed as described for A. Three independent clones, in the case of HeLa transfectants (K9, K1 
and K6), and CHO transfectants (K2, K3 and K7), and one clone (K12), in the case of NIH transfectants, were analyzed. (C) Controls 
were either vector transfectants (HeLa and NIH cells) or the parental cell line (CHO cells). Error bars indicate the range of triplicate 
determinations. 
Figure 6.  Sulfate  uptake  is enhanced  in HeLa  PKCIx  transfec- 
tants. 105 cells were grown in 24-well plates and processed as de- 
scribed  in  the  legend  of Fig.  5.  After  labeling,  the  cells  were 
washed three times with 500 ~1 DMEM to remove free [3551504, 
The cells were lysed, and incorporated [35S]504 was measured by 
liquid scintillation counting. Error bars indicate the range of trip- 
licate assays. 
inhibits  (Lehel  et  al.,  1995)  sulfated  GAG  chain  release, 
respectively. Accordingly, as GAG chain release is a para- 
digm of constitutive secretion (Chanat and Huttner, 1991), 
these data make PKCI~ and PKC~ good candidates for an- 
tagonistic regulators of secretory processes. 
Of particular significance for regulation of PKCtx activ- 
ity at the Golgi could be the finding that PKCp~ possesses a 
PH-domain in its regulatory region (Gibson  et  al.,  1994). 
PH-domains  are  structural  elements  of various  proteins 
known or supposed  to play a  role  in  signal  transduction 
and,  in  analogy to  SH2  and  SH3  domains,  are  currently 
considered as potential modules for protein-protein inter- 
actions.  Although to date  limited data about direct inter- 
action of defined proteins via the PH-domain exist (Paw- 
son,  1995),  there  is  evidence  that  certain  PH-domains 
contribute  to the  binding  of the  13-y subunit  of heterotri- 
meric G-proteins  (Koch et al.,  1993).  Novel and classical 
heterotrimeric  G-proteins  appear  to play critical  roles  in 
different steps of vesicular transport through the Golgi ap- 
paratus (Kehlenbach et al., 1994; Stow et al., 1991; Bauer- 
feind  and  Huttner,  1993)  and  could  potentially  interact 
with the PKCIx PH-domain. 
Independent of a potential function as a protein-interac- 
tion  domain,  PH-domains  have  been  described  as  target 
structures of phospholipids. In particular, specific associa- 
tion with phosphoinositides,  e.g., phosphatidylinositol-4,5- 
bisphosphate  (PIPe),  has  been  demonstrated  for several 
PH-domains (Harlan et al., 1994). In the context discussed 
here, it is noteworthy that a role for phosphoinositides in 
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key regulatory molecule ADP-ribosylation factor has been 
found  to  activate  phospholipase  D  in  a  PIP2-dependent 
manner (Kahn et al., 1993).  In addition, activity of ADP- 
ribosylation factor GTPase-activating protein is enhanced 
by PIP2 and phosphatidic acid, the product of phosphati- 
dylcholine hydrolysis by phospholipase D  (Randazzo  and 
Kahn,  1994).  PIP2 was also  shown to be  an  activator  of 
PKCI~  kinase  activity  (Dieterich  et  al.,  1996).  A  role of 
phosphoinositides was already evident from the previous 
cloning  of the  vacuolar  protein-sorting  protein  of yeast, 
VPS34 (Schu et al., 1993). The recent identification of the 
human  homologue  of  VPS34,  a  phosphatidylinositol-3- 
phosphate-specific kinase (Volinia et al., 1995), shows that 
this sorting mechanism is highly conserved throughout the 
species. 
Based on the above-mentioned  evidence for an impor- 
tant  role  of  heterotrimeric  G-proteins  as  well  as  phos- 
phatidylinositols  in  Golgi  transport  processes,  and  our 
finding that PKC~ is located  at the Golgi, affects sulfate 
uptake as well as GAG chain release, and possesses a PH- 
domain, it is possible that PKC~ activity is under control 
of  Golgi-localized  G-proteins  and/or  phosphatidylinosi- 
tols. With the availability  of purified recombinant PKCIx 
protein,  this  hypothesis  can  now  be  experimentally  ad- 
dressed. 
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